Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
dorsaVi Limited (AU:DVL)
ASX:DVL
Holding AU:DVL?
Track your performance easily
DVL Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.01 - AU$0.03
Previous CloseAU$0.01
Volume3.22M
Average Volume (3M)1.45M
Market Cap
AU$9.51M
Enterprise ValueAU$10.24M
Total Cash (Recent Filing)AU$449.70K
Total Debt (Recent Filing)AU$1.18M
Price to Earnings (P/E)―
Beta-0.74
Next Earnings
Mar 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares OutstandingN/A
10 Day Avg. Volume4,208,142
30 Day Avg. Volume1,450,890
Standard Deviation0.31
R-Squared0.09
Alpha0.00284
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)2.35
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
dorsaVi Limited News
PremiumCompany Announcements
dorsaVi Limited Pursues Blockchain for Data Security Boost
PremiumCompany Announcements
DorsaVi Eyes Blockchain for Enhanced Data Security
PremiumCompany Announcements
DorsaVi Issues 50 Million Unquoted Options
PremiumCompany Announcements
dorsaVi Limited Expands with Issuance of New SharesPremiumCompany Announcements
dorsaVi Limited Issues Shares to Directors
PremiumCompany Announcements
DorsaVi Limited Lists 50 Million Shares on ASXPremiumCompany Announcements
DorsaVi Limited Announces New Securities Issuance
PremiumCompany Announcements
dorsaVi Limited Partners with 62 Capital for Strategic GrowthOptions Prices
Currently, No data available
---
Ownership Overview
DVL FAQ
What was dorsaVi Limited’s price range in the past 12 months?
dorsaVi Limited lowest share price was AU$0.01 and its highest was AU$0.03 in the past 12 months.
What is dorsaVi Limited’s market cap?
Currently, no data Available
When is dorsaVi Limited’s upcoming earnings report date?
dorsaVi Limited’s upcoming earnings report date is Mar 04, 2025 which is in 102 days.
How were dorsaVi Limited’s earnings last quarter?
dorsaVi Limited released its earnings results on Aug 30, 2024. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
Is dorsaVi Limited overvalued?
According to Wall Street analysts dorsaVi Limited’s price is currently Overvalued.
Does dorsaVi Limited pay dividends?
dorsaVi Limited does not currently pay dividends.
What is dorsaVi Limited’s EPS estimate?
dorsaVi Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does dorsaVi Limited have?
dorsaVi Limited has 731,237,900 shares outstanding.
What happened to dorsaVi Limited’s price movement after its last earnings report?
dorsaVi Limited reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of dorsaVi Limited?
Currently, no hedge funds are holding shares in AU:DVL
---
dorsaVi Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:DVL Sentiment 100%
Sector Average 67%
Sector Average 67%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
16.66%
12-Months-Change
Fundamentals
Return on Equity
-92.34%
Trailing 12-Months
Asset Growth
-18.79%
Trailing 12-Months
Company Description
dorsaVi Limited
DorsaVi Ltd is engaged in a distribution of innovative motion analysis technologies. It makes wearable sensors, software, and sophisticated algorithms that measure movement and muscle activation at around 200 frames per second. The company's products include ViSafe (Workplace), ViMove (Clinic), ViPerform (Elite Sports), and others. The firm operates in two segments: Clinical; Workplace. Its geographical segments are Australia, Europe, and the United States.
---
Technical Analysis
---